Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Liver Disease and Transplantation, and Hepatitis B Virus Studies.
Guidance for Liver Rehabilitation in Chronic Liver Disease.
Impact of Fatigue on Patient‐Reported Outcomes and Work Productivity in Chronic Hepatitis B and C: Insights From a Multinational Registry Study
Metabolic Effect on Serum Mac-2 Binding Protein Glycan Isomer Level and Its Normal Range in the Health Checkup Examinee.
Physician Perspectives on Hepatitis C Treatment During Pregnancy: A Multinational Multispecialty Survey.
Machine Learning Approach Enables Highly Accurate Identification of At-Risk Metabolic Dysfunction-Associated Steatohepatitis.
Impact of Fatigue on Patient-Reported Outcomes and Work Productivity in Chronic Hepatitis B and C: Insights From a Multinational Registry Study.
Employment Status of Patients With Liver Disease: A Nationwide Questionnaire Survey in Japan.
The Hepatic Steatosis Diagnostic Performance Using Attenuation Imaging With the Magnetic Resonance Imaging-Based Proton Density Fat Fraction as the Reference Standard: A Large, Prospective, Multicenter Cohort Study in Japan.
Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational Cohort.
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis
Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis
Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine Countries
Survey on Awareness of Helicobacter pylori and Gastric Cancer in the Japanese Population Using an Internet Survey.
Human Leukocyte Antigen Genotypes Affect Hepatitis B Virus Mutations Associated With Hepatocellular Carcinoma.
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease
Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study
Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator‐activated receptor α modulator (SPPARMα), versus placebo in patients with non‐alcoholic fatty liver disease
Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), versus placebo in patients with non-alcoholic fatty liver disease.
Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry
Clinical Profiles of Asians with NAFLD: A Systematic Review and Meta-Analysis
ALT Levels for Asians With Metabolic Diseases: A Meta‐analysis of 86 Studies With Individual Patient Data Validation
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.
Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease
Influence of muscle fiber type composition on early fat accumulation under high-fat diet challenge
The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease